Surfactants, Nanomedicines and Nanocarriers: A Critical Evaluation on Clinical Trials

Advances, perspectives and innovation in drug delivery have increased in recent years; however, there is limited information available regarding the actual presence of surfactants, nanomedicines and nanocarriers in investigational medicinal products submitted as part of a request for authorization o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dri, Diego Alejandro, Marianecci, Carlotta, Carafa, Maria, Gaucci, Elisa, Gramaglia, Donatella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999832/
https://www.ncbi.nlm.nih.gov/pubmed/33805639
http://dx.doi.org/10.3390/pharmaceutics13030381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999832/
https://www.ncbi.nlm.nih.gov/pubmed/33805639
http://dx.doi.org/10.3390/pharmaceutics13030381

Ejemplares similares